본문 바로가기
KERD
논문KCI 등재

『傷寒論』 辨病 診斷體系에 근거하여 生薑瀉心湯 투여 후 호전된 피로를 주소로 하는 Post-COVID-19 Syndrome 1례

A Case Report of Post-COVID-19 Syndrome with Fatigue Treated with Saengkangsasim-tang based on Disease Pattern Identification Diagnostic System by Shanghanlun Provisions

김상호|최해윤|황보민|서영호
대한상한금궤의학회 (Korean Medical Association of Clinical Sanghan - Geumgwe)|2022.12|대한상한금궤의학회지 (The Journal of Korean Medical Association of Clinical Sanghan-Geumgwe)|제14권 제1호|pp. 69-79|DOI 10.22891/kmedia.2022.14.1.69

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

FatigueShanghanlunPost-COVID-19 SyndromeSaengkangsasim-tangHerbal-Formulae medicine.

초록

Objective：Fatigue is the most common symptom in post-COVID-19 syndrome. We report the case of a patient with post-COVID-19 syndrome with fatigue treated using herbal medicine (Saengkangsasim-tang). Methods：A 64-year-old man had severe fatigue for 4 months after a severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection. Saengkangsasim-tang was administered to this patient based on the disease pattern identification diagnostic system by Shanghanlun provisions (DPIDS). We used the Numeric Rating Scale (NRS) and Beck Depression Inventory (BDI) to evaluate the effectiveness of Saengkangsasim-tang for fatigue in the patient with post-COVID-19 syndrome. Results：According to DPIDS, the patient was diagnosed with the provision 157. After administration of Saengkangsasim-tang for 30days, the fatigue based on NRS and depression based on BDI were improved. Conclusions：The administration of Saengkangsasim-tang to patients with post-COVID-19 syndrome with fatigue, diagnosed according to the Shanghanlun provision 157, may be effective.

Abstract

Objective：Fatigue is the most common symptom in post-COVID-19 syndrome. We report the case of a patient with post-COVID-19 syndrome with fatigue treated using herbal medicine (Saengkangsasim-tang). Methods：A 64-year-old man had severe fatigue for 4 months after a severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection. Saengkangsasim-tang was administered to this patient based on the disease pattern identification diagnostic system by Shanghanlun provisions (DPIDS). We used the Numeric Rating Scale (NRS) and Beck Depression Inventory (BDI) to evaluate the effectiveness of Saengkangsasim-tang for fatigue in the patient with post-COVID-19 syndrome. Results：According to DPIDS, the patient was diagnosed with the provision 157. After administration of Saengkangsasim-tang for 30days, the fatigue based on NRS and depression based on BDI were improved. Conclusions：The administration of Saengkangsasim-tang to patients with post-COVID-19 syndrome with fatigue, diagnosed according to the Shanghanlun provision 157, may be effective.

참고문헌 (30)

  1. A.V. Raveendran, "Long COVID: An overview", Diabetes &Metabolic Syndrome:Clinical Research &Reviews, 15(3), pp.869~875 (2021), Elsevier BV[DOI]
  2. Qing Han, "Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms", Pathogens, 11(2), pp.269~ (2022), MDPI AG[DOI]
  3. Felicia Ceban, "Fatigue and cognitive impairment in Post-COVID-19 Syndrome: A systematic review and meta-analysis", Brain, Behavior, and Immunity, 101, pp.93~135 (2022), Elsevier BV[DOI]
  4. Nicola Latronico, "Physical, cognitive and mental health outcomes in 1-year survivors of COVID-19-associated ARDS", Thorax, 77(3), pp.300~303 (2021), BMJ[DOI]
  5. Lixue Huang, "1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study", The Lancet, 398(10302), pp.747~758 (2021), Elsevier BV[DOI]
  6. Ramon Sabes-Figuera, "The hidden cost of chronic fatigue to patients and their families", BMC Health Services Research, 10(1), pp.1~7 (2010), Springer Science and Business Media LLC[DOI]
  7. David Y.W. Lee, "Traditional Chinese herbal medicine at the forefront battle against COVID-19: Clinical experience and scientific basis", Phytomedicine, 80, pp.153337~ (2021), Elsevier BV[DOI]
  8. The Society of Stroke on Korean Medicine, "Chronic Fatigue : Clinical Practice Guideline of Korean Medecine" (2021), Gunjachulpansa
  9. Kazuki Tokumasu, "Application of Kampo Medicines for Treatment of General Fatigue Due to Long COVID", Medicina, 58(6), pp.730~ (2022), MDPI AG[DOI]
  10. Ansul Kumar, "Role of herbal medicines in the management of patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials", Journal of Traditional and Complementary Medicine, 12(1), pp.100~113 (2022), Elsevier BV[DOI]
  11. Shiraish Y, "Illustrate Shanghanlun", pp.156~169 (2006), Jeonpagwahaksa
  12. Ryu JM, "The effects of Jowiseungchung-tang versus fluoxetine in the chronic mild stress model of depression in rats", J of Oriental Neuropsychiatry, 15(1), pp.43~64 (2004)
  13. 이선구, "베체트병의 동물모형에 대한 瀉心湯類 투여 효과에 관한 연구", 동의생리병리학회지, 18(4), pp.1061~1070 (2004), 한의병리학회
  14. Lee SJ, "A diagnostic system and clinical application based on six meridian patterns and provisions" (2013), KMediACs publishing house
  15. 김대담, "‘『傷寒論』六經과 條文에 근거한 診斷體系’ 命名에 대한 考察 및 提案", 대한상한금궤의학회지, 5(1), pp.19~29 (2013), 대한상한금궤의학회[DOI]
  16. Oh HM, "A comparative study on physiopathology of depression by Korean medicine and conventional medicine", Journal of Haehwa Medicine, 26(1), pp.11~18 (2017)
  17. 이욱제, "『傷寒論』辨病診斷體系에 근거하여 生薑瀉心湯 투여 후 호전된 달리 분류되지 않는 두통 증례 2례", 대한상한금궤의학회지, 13(1), pp.133~144 (2021), 대한상한금궤의학회
  18. Lee SI, "Comparison of Shanghanlun", pp.198~206 (2015), KMediACs publishing house
  19. Chaolin Huang, "6-month consequences of COVID-19 in patients discharged from hospital: a cohort study", The Lancet, 397(10270), pp.220~232 (2021), Elsevier BV[DOI]
  20. Ani Nalbandian, "Post-acute COVID-19 syndrome", Nature Medicine, 27(4), pp.601~615 (2021), Springer Science and Business Media LLC[DOI]
  21. Oh HM, "A comparative study on physiopathology of depression by Korean medicine and conventional medicine", Journal of Haehwa Medicine, 26(1), pp.11~18 (2017)
  22. Hwang UH, "Oriental Psychiatry", pp.505~611 (1987), Modern Medical books
  23. 이은희, "우울증 변증도구 개발을 위한 기초연구", 동의신경정신과학회지, 24(4), pp.435~450 (2013), 대한한방신경정신과학회
  24. Mun JJ, "Sanghanlunjeonghae", 330~331 (1998)
  25. Ha YS, "The Etymology Dictionary of Chinese Characters", pp.496~762 (2014), Publication 3
  26. Ha HY, "Diagnostic of chest bind in GanPyeongShanghanlun 15 letters provision", Journal of Korean Medical Association of Clinical Sanghan-Geumgwe, 10(1), pp.1~21 (2018)
  27. Committee on the Compilation of Basic 808Chinese Characters, "The Basic 808 Chinese Characters in China, Korea and Japan", pp.824~ (2016), JoongAng Ilbo
  28. 서영호, "『傷寒論』 辨病診斷體系에 근거하여 小靑龍湯 투여 후 호전된 耳鳴 증례 1례", 대한상한금궤의학회지, 12(1), pp.71~78 (2020), 대한상한금궤의학회
  29. Lauren B. Krupp, "The fatigue severity scale:Application to patients with multiple sclerosis and systemic lupus erythematosus", Archives of Neurology, 46(10), pp.1121~1123 (1989), American Medical Association (AMA)[DOI]
  30. Manoj Sivan, "Assessing long-term rehabilitation needs in COVID-19 survivors using a telephone screening tool (C19-YRS tool)", Advances in Clinical Neurosciences and Rehabilitation, 19(4), pp.14~17 (2020), Whitehouse Publishing[DOI]

이 간행물의 다른 논문 (5건)

『傷寒論』 ‘發作’과 뇌전증의 연관성 : 다수증례보고이숭인, 이성준, 김민환, 임규상, 윤용갑pp. 1-26『傷寒論』 辨病診斷體系에 근거하여 茯苓桂枝白朮甘草湯 투여 후 호전된 부정맥 증례 1례이욱제pp. 27-39자연어 처리 기반 『傷寒論』 辨病診斷體系 분류를 위한 기계학습 모델 선정김영남pp. 41-50『傷寒論 吳茱萸湯의 임상연구 분석이숭인, 정종길, 최현범, 변성희pp. 51-68『傷寒論』 陽明病 小承氣湯으로 진단된 과민 대장 증후군 환자 1례이미현, 이성준, 최재영, 이숭인pp. 81-93
원문 보기